These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 36091792)

  • 1. Dietary stilbenes as modulators of specific miRNAs in prostate cancer.
    Levenson AS
    Front Pharmacol; 2022; 13():970280. PubMed ID: 36091792
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metastasis-associated protein 1-mediated antitumor and anticancer activity of dietary stilbenes for prostate cancer chemoprevention and therapy.
    Levenson AS
    Semin Cancer Biol; 2022 May; 80():107-117. PubMed ID: 32126261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resveratrol and pterostilbene as a microRNA-mediated chemopreventive and therapeutic strategy in prostate cancer.
    Kumar A; Rimando AM; Levenson AS
    Ann N Y Acad Sci; 2017 Sep; 1403(1):15-26. PubMed ID: 28662290
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dietary Pterostilbene for MTA1-Targeted Interception in High-Risk Premalignant Prostate Cancer.
    Hemani R; Patel I; Inamdar N; Campanelli G; Donovan V; Kumar A; Levenson AS
    Cancer Prev Res (Phila); 2022 Feb; 15(2):87-100. PubMed ID: 34675064
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dietary pterostilbene is a novel MTA1-targeted chemopreventive and therapeutic agent in prostate cancer.
    Dhar S; Kumar A; Zhang L; Rimando AM; Lage JM; Lewin JR; Atfi A; Zhang X; Levenson AS
    Oncotarget; 2016 Apr; 7(14):18469-84. PubMed ID: 26943043
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resveratrol and pterostilbene epigenetically restore PTEN expression by targeting oncomiRs of the miR-17 family in prostate cancer.
    Dhar S; Kumar A; Rimando AM; Zhang X; Levenson AS
    Oncotarget; 2015 Sep; 6(29):27214-26. PubMed ID: 26318586
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epigenetic potential of resveratrol and analogs in preclinical models of prostate cancer.
    Kumar A; Dhar S; Rimando AM; Lage JM; Lewin JR; Zhang X; Levenson AS
    Ann N Y Acad Sci; 2015 Aug; 1348(1):1-9. PubMed ID: 26214308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In Vitro Anticancer Properties of Table Grape Powder Extract (GPE) in Prostate Cancer.
    Kumar A; D'silva M; Dholakia K; Levenson AS
    Nutrients; 2018 Nov; 10(11):. PubMed ID: 30463302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting MTA1/HIF-1α signaling by pterostilbene in combination with histone deacetylase inhibitor attenuates prostate cancer progression.
    Butt NA; Kumar A; Dhar S; Rimando AM; Akhtar I; Hancock JC; Lage JM; Pound CR; Lewin JR; Gomez CR; Levenson AS
    Cancer Med; 2017 Nov; 6(11):2673-2685. PubMed ID: 29024573
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pterostilbene acts through metastasis-associated protein 1 to inhibit tumor growth, progression and metastasis in prostate cancer.
    Li K; Dias SJ; Rimando AM; Dhar S; Mizuno CS; Penman AD; Lewin JR; Levenson AS
    PLoS One; 2013; 8(3):e57542. PubMed ID: 23469203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MTA1-Dependent Anticancer Activity of Gnetin C in Prostate Cancer.
    Kumar A; Dholakia K; Sikorska G; Martinez LA; Levenson AS
    Nutrients; 2019 Sep; 11(9):. PubMed ID: 31487842
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Therapeutic Efficacy and Mechanism of Action of Gnetin C, a Natural Compound from the Melinjo Plant, in a Preclinical Mouse Model of Advanced Prostate Cancer.
    Campanelli G; Francois E; Parupathi P; Devarakonda LS; Yang C; Kumar A; Levenson AS
    Cancers (Basel); 2024 Mar; 16(7):. PubMed ID: 38611022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resveratrol enhances p53 acetylation and apoptosis in prostate cancer by inhibiting MTA1/NuRD complex.
    Kai L; Samuel SK; Levenson AS
    Int J Cancer; 2010 Apr; 126(7):1538-48. PubMed ID: 19810103
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resveratrol regulates PTEN/Akt pathway through inhibition of MTA1/HDAC unit of the NuRD complex in prostate cancer.
    Dhar S; Kumar A; Li K; Tzivion G; Levenson AS
    Biochim Biophys Acta; 2015 Feb; 1853(2):265-75. PubMed ID: 25447541
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MTA family of proteins in prostate cancer: biology, significance, and therapeutic opportunities.
    Levenson AS; Kumar A; Zhang X
    Cancer Metastasis Rev; 2014 Dec; 33(4):929-42. PubMed ID: 25332143
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gnetin C Intercepts MTA1-Associated Neoplastic Progression in Prostate Cancer.
    Parupathi P; Campanelli G; Deabel RA; Puaar A; Devarakonda LS; Kumar A; Levenson AS
    Cancers (Basel); 2022 Dec; 14(24):. PubMed ID: 36551523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Honokiol abrogates leptin-induced tumor progression by inhibiting Wnt1-MTA1-β-catenin signaling axis in a microRNA-34a dependent manner.
    Avtanski DB; Nagalingam A; Kuppusamy P; Bonner MY; Arbiser JL; Saxena NK; Sharma D
    Oncotarget; 2015 Jun; 6(18):16396-410. PubMed ID: 26036628
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resveratrol and prostate cancer: promising role for microRNAs.
    Dhar S; Hicks C; Levenson AS
    Mol Nutr Food Res; 2011 Aug; 55(8):1219-29. PubMed ID: 21714127
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic Potential of Gnetin C in Prostate Cancer: A Pre-Clinical Study.
    Gadkari K; Kolhatkar U; Hemani R; Campanelli G; Cai Q; Kumar A; Levenson AS
    Nutrients; 2020 Nov; 12(12):. PubMed ID: 33255879
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pterostilbene inhibits MTA1/HDAC1 complex leading to PTEN acetylation in hepatocellular carcinoma.
    Qian YY; Liu ZS; Yan HJ; Yuan YF; Levenson AS; Li K
    Biomed Pharmacother; 2018 May; 101():852-859. PubMed ID: 29635894
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.